EW

Edwards Lifesciences Corp
NYSE
76.55
-1.01
-1.30%
After Hours: 76.51 -0.04 -0.05% 18:02 12/02 EST
OPEN
76.42
PREV CLOSE
77.56
HIGH
76.98
LOW
75.02
VOLUME
3.16M
TURNOVER
0
52 WEEK HIGH
131.73
52 WEEK LOW
67.13
MARKET CAP
47.33B
P/E (TTM)
32.96
1D
5D
1M
3M
1Y
5Y
Wolfe Research Downgrades Edwards Lifesciences to Peer Perform
Benzinga · 1d ago
Expert Ratings for Edwards Lifesciences
Benzinga · 5d ago
Reata Pharmaceuticals To Jump 220%? Plus JP Morgan Predicts $51 For Las Vegas Sands
Benzinga · 5d ago
15 Analysts Have This to Say About Edwards Lifesciences
Benzinga · 5d ago
RBC Capital Maintains Outperform on Edwards Lifesciences, Lowers Price Target to $105
Benzinga · 5d ago
RBC Cuts Price Target on Edwards Lifesciences to $105 From $118 Amid Foreign Exchange Impact on Margins, Keeps Outperform Rating
RBC Cuts Price Target on Edwards Lifesciences to $105 From $118 Amid Foreign Exchange Impact on Margins, Keeps Outperform Rating
MT Newswires · 5d ago
Edwards Lifesciences Says Tricuspid Valve Replacement Study Showed Survival of 90.1% After One Year
Edwards Lifesciences Says Tricuspid Valve Replacement Study Showed Survival of 90.1% After One Year
MT Newswires · 5d ago
EDWARDS ANNOUNCES ONE-YEAR DATA ON TRANSFEMORAL TRANSCATHETER TRICUSPID VALVE REPLACEMENT
Edwards Lifesciences Corporation (NYSE: EW) announced that one-year results on patients treated in the single-arm, prospective, global, multi-center TRISCEND study of the company's EVOQUE transcatheter tricuspid valve replacement system demonstrated favora...
PR Newswire · 6d ago
More
About EW
Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease.

Webull offers kinds of Edwards Lifesciences Corp stock information, including NYSE:EW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EW stock methods without spending real money on the virtual paper trading platform.